Effect of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease. 1998

A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
Department of Thoracic Medicine, Royal Free Hospital, London, U.K.

It has been well established that lung mucociliary clearance is depressed in patients with chronic obstructive pulmonary disease. This study examines whether oral antibiotics have a detectable effect on this clearance mechanism during exacerbation in patients with such disease. Twelve patients with a mean +/- SE age of 63 +/- 2 years participated in a randomized, double-blind, parallel group study to assess the effect of 1 week of treatment with amoxycillin (500 mg t.d.s.) or ciprofloxacin (500 mg b.d.) on lung mucociliary clearance during exacerbation. Lung mucociliary clearance rates were measured by a non-invasive radioaerosol technique. Both drugs on average resulted in small, non-significant, enhancement of mucociliary clearance. Following treatment, the numbers of coughs were reduced in both groups and significantly (P < 0.05) after treatment with ciprofloxacin. Sputum production was also significantly reduced (P < 0.01) in both groups. The magnitude of improvement in lung mucociliary clearance was relatively modest following 1 week of treatment with either antibiotic. Since the number of coughs was significantly less after ciprofloxacin treatment the measured enhancement of lung mucociliary transport is probably, however, an underestimate.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009079 Mucociliary Clearance A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. Mucociliary Transport,Clearance, Mucociliary,Clearances, Mucociliary,Mucociliary Clearances,Mucociliary Transports,Transport, Mucociliary,Transports, Mucociliary
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003371 Cough A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs. Coughs
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
April 2009, Respiratory medicine,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
May 1993, Chest,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
December 2014, Collegium antropologicum,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
January 2008, Respiration; international review of thoracic diseases,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
March 2001, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
October 2010, Archivos de bronconeumologia,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
September 2009, The Medical journal of Malaysia,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
November 2015, Cell biochemistry and biophysics,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
December 1981, Chest,
A Hasani, and D Pavia, and S Rotondetto, and S W Clarke, and M A Spiteri, and J E Agnew
November 1995, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!